Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors. - Sloop,K.W.; Cao,J.X-C.; Siesky,A.M.; Zhang,H.Y.; Bodenmiller,D.M.; Cox,A.L.; Jacobs,S.J.; Moyers,J.S.; Owens,R.A.; Showalter,A.D.; Brenner,M.B.; Raap,A.; et al. (J Clin Invest, 2004)